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chwann cell factor 1 (SC1), a p75 neurotrophin recep-
tor–interacting protein, is a member of the positive
regulatory/suppressor of variegation, enhancer of zeste,
trithorax (PR/SET) domain-containing zinc finger protein
family, and it has been shown to be regulated by serum
and neurotrophins. SC1 shows a differential cytoplasmic
and nuclear distribution, and its presence in the nucleus
correlates strongly with the absence of bromodeoxyuridine
(BrdU) in these nuclei. Here, we investigated potential
transcriptional activities of SC1 and analyzed the function
of its various domains. We show that SC1 acts as a transcrip-
tional repressor when it is tethered to Gal4 DNA-binding
S
 
domain. The repressive activity requires a trichostatin
A–sensitive histone deacetylase (HDAC) activity, and SC1
is found in a complex with HDACs 1, 2, and 3. Transcrip-
tional repression exerted by SC1 requires the presence of
its zinc finger domains and the PR domain. Additionally,
these two domains are involved in the efficient block of
BrdU incorporation by SC1. The zinc finger domains are
also necessary to direct SC1’s nuclear localization. Lastly,
SC1 represses the promoter of a promitotic gene, 
 
cyclin E
 
,
suggesting a mechanism for how growth arrest is regulated
by SC1.
 
Introduction
 
Schwann cell factor 1 (SC1) is a p75 neurotrophin receptor
(NTR)–interacting protein (Chittka and Chao, 1999). It
belongs to a small group of proteins referred to as the retino-
blastoma-interacting zinc finger (RIZ) family of transcription
factors. These proteins are characterized by the presence of
zinc finger and positive regulatory/suppressor of variegation,
enhancer of zeste, trithorax (PR/SET) domains, and are
involved in cell differentiation and tumorigenesis (for review
see Huang et al., 1998). Proteins containing the PR/SET
domain include the lymphocyte PRDI-BF1/BLIMP protein
(Keller and Maniatis, 1991), RIZ (Buyse et al., 1995), and
the EVI1 gene (Fears et al., 1996). The presence of the PR/
SET domain makes these proteins distinct from a multitude
of other zinc finger motif-bearing proteins. The PR/SET
domain is a modified SET domain. SET domain proteins
possess protein methyltransferase activity and have been
shown to methylate histones, thus regulating chromatin
structure and transcription (Rea et al., 2000; Strahl et al.,
2002). However, close inspection of the amino acid sequences
of the PR domains reveals striking differences in the highly
conserved residues necessary for the methyltransferase activity
of the SET domain (Kouzarides, 2002). The zinc finger
domains and the PR/SET domain of SC1 imply that this
protein may mediate transcriptional activities. Thus, transcrip-
tional activities of repressive and activating nature have been
described for RIZ (Xie et al., 1997; Abbondanza et al.,
2000; Steele-Perkins et al., 2001), Blimp-1/PRDI-BF1
(Lin et al., 1997; Ren et al., 1999; Yu et al., 2000), and
Evi-1 (Kurokawa et al., 1998; Izutsu et al., 2001; Palmer et
al., 2001). SC1 is the first member of this family that is
implicated in the neurotrophin signaling.
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Neurotrophins, such as NGF, BDNF, and NT-3, are im-
portant survival and differentiation factors. The neuro-
trophins interact with two distinct classes of receptors,
members of the Trk tyrosine kinase receptor subfamily
and p75NTR, a member of the TNF receptor superfam-
ily (Chao and Hempstead, 1995). There is evidence that
p75NTR can function as a cell death receptor (Casaccia-
Bonnefil et al., 1996; Frade et al., 1996; Bamji et al., 1998;
Frade and Barde, 1998). Several proteins that interact with
p75NTR have been shown to transduce apoptotic signaling.
These include NRIF (Casademunt et al., 1999), NRAGE
(Salehi et al., 2000), and NADE (Mukai et al., 2000). Inter-
estingly, p75NTR is expressed very early during develop-
ment (Yan and Johnson, 1987, 1988), before differentiation
of many precursor cells of the nervous system and before the
onset of programmed neuronal cell death. This observation
makes it a candidate for a receptor functioning in the con-
trol of precursor cell proliferation and differentiation. Sup-
porting this idea is the observation that several proteins
which interact with p75NTR induce growth arrest. Expres-
sion of SC1, for example, was previously found to be corre-
lated with a decrease in BrdU incorporation (Chittka and
Chao, 1999).
To elucidate the mechanism by which SC1 transduces the
neurotrophin signaling, we began to analyze its potential
transcriptional activity. In a reporter gene assay, SC1 acted as
a transcriptional repressor. Both the zinc finger domains as
well as the PR/SET domain are necessary for SC1 to act as a
repressor, and are needed to effectively block BrdU incorpo-
ration into cell nuclei. The repression exerted by SC1 re-
quired the activity of trichostatin A (TSA)–sensitive histone
deacetylases (HDACs), and SC1 was found in the complex
with HDAC 1, 2, and 3. Further, we show that SC1 behaves
as a transcriptional repressor upon NGF application to the
cells transfected with both SC1 and either p75NTR or TrkA.
We found the zinc finger domains of SC1 are necessary for its
nuclear localization. Finally, our analysis of genes transcrip-
tionally regulated by SC1 revealed that SC1 down-regulates
the expression of a promitotic gene, 
 
cyclin E
 
, consistent with
its ability to block DNA replication as measured by BrdU in-
corporation. These results implicate SC1 as a potential tran-
scriptional mediator of NGF signaling that may be involved
in modifying the chromatin structure during differentiation.
 
Results
 
Regulation of the subcellular distribution of SC1
 
SC1 is localized to both the nucleus and the cytoplasm of
COS1 and Schwann cells (Chittka and Chao, 1999). We
sought to determine which domains of SC1 were responsible
for this differential distribution. To address this question,
we generated a series of deletion mutants of SC1 fused to
GFP. These include full-length SC1 or deletions lacking ei-
ther the acidic COOH terminus, the zinc finger domains, or
the PR/SET domain (see Fig. 1 for a schematic representa-
tion of the constructs used in these experiments). These con-
structs were then transfected into COS1 cells, and the distri-
bution of each protein was investigated. The results of these
experiments are shown in Fig. 1 (a–e). GFP alone distrib-
uted to the cytoplasm and nucleus (Fig. 1 a). Full-length
SC1 as well as SC1
 

 
PR and SC1
 

 
C were found predomi-
nantly in the nucleus (Fig. 1, b, c, and e, respectively), as can
be visualized by their overlapping distribution with the
Hoechst stain in the nuclei. Strikingly, the deletion of zinc
finger domains resulted in a cytoplasmic distribution of SC1
(Fig. 1 d). Therefore, we concluded that zinc finger domains
are necessary for nuclear localization of SC1.
 
SC1 is an HDAC-dependent transcriptional repressor
 
The localization of SC1 is highly regulated, and translocation
of the protein to the nucleus was closely correlated with a loss
of BrdU incorporation (Chittka and Chao, 1999). These re-
sults suggest that SC1 may be involved in transcriptional
events associated with growth arrest. To assess whether SC1
possessed the ability to modulate gene transcription, we fused
the coding sequence of SC1 to the Gal4 DNA-binding do-
main (DBD; see Fig. 2 B for the schematic representation of
the effector and reporter constructs). Fusion of these trun-
cated SC1 proteins with Gal4-DBD, which contains an en-
dogenous NLS, ensured nuclear localization of the proteins
(see Fig. 5). A luciferase reporter under transcriptional con-
trol of Gal4 upstream activating sequences was used for mea-
suring transcription relative to a control effector without SC1
(i.e., Gal4 alone). Gal4-SC1 or Gal4 and the reporter DNAs
were cotransfected into HEK293 cells, and luciferase activity
was measured 48 h later.
A reduction in luciferase activity was consistently observed
when SC1 was fused to the Gal4-DBD and cotransfected
with the reporter as compared with the luciferase activity
measured in the presence of Gal4-DBD only (Fig. 2 A, lanes
1 and 2). We used a reporter construct where the luciferase
gene was under the control of the TATA element only to
verify the specificity of the results observed when luciferase is
Figure 1. The zinc finger domains of SC1 are necessary for nuclear 
localization. Localization of GFP, GFP-SC1, GFP-SC1PR, GFP-
SC1ZF, and GFP-SC1C was assayed 48 h after transient transfection 
in COS1 cells. Cells were assessed for Hoechst staining (blue) to visu-
alize nuclei, and for GFP fluorescence to visualize overexpressed 
proteins. COS1 cells were transfected with (a) GFP, (b) GFP-SC1, (c) 
GFP- SC1PR, (d) GFP-SC1ZF, and (e) GFP-SC1C. Bar, 20 m.
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driven by the Gal4 upstream activating sequence. No repres-
sion was measured when SC1 was compared with Gal4
alone in these reporter assays (Fig. 2 A, lanes 3 and 4), sup-
porting the conclusion that SC1 acts as a transcriptional re-
pressor with a responsive promoter.
To define the domains of SC1 responsible for the repres-
sive activity, we created truncated fusion proteins of NH
 
2
 
-
terminally Flag-tagged SC1 with the Gal4-DBD and used
them for transfection of HEK293 cells in our reporter as-
says. Three truncated proteins were made: (1) 
 

 
754
 

 
798
lacks the extreme COOH terminus, which contains a
highly acidic domain; (2) 
 

 
583
 

 
798 lacks the six zinc fin-
ger domains in addition to the COOH-terminal domain;
and (3) 
 

 
404
 

 
798 lacks the PR domain and the entire
COOH terminus. (see Fig. 2 B for the schematic represen-
tation of the fusion proteins). Expression of these proteins
was verified by transfection of HEK293 cells and subse-
quent immunoprecipitation of the proteins using anti-Flag
antibodies (Fig. 2 C).
We observed that deletion of the zinc finger domains
from SC1 leads to a loss of its repressive activity (Fig. 2 B,
compare lane 
 

 
583–798 lacking the zinc fingers with Gal4
alone), whereas deletion of the acidic-rich COOH ter-
minus had no influence on the repression by SC1 (Fig. 2
B, compare lane 
 

 
754–798 lacking the COOH-terminus
with Gal4 alone). Interestingly, deletion of the PR domain
rendered SC1 a transcriptional activator, as can be seen
from an increase in luciferase activity over the control lev-
els (Fig. 2 B, compare lane 
 

 
404–798 with Gal4). Such
behavior has been observed for Blimp/PRDI-BF1 (Ren et
al., 1999; Yu et al., 2000). We noticed that the truncations
of the zinc fingers and the PR/SET domain led to a reduc-
tion of the total protein levels detected. To exclude the
possibility that the increase in the luciferase activity ob-
served upon the truncations of SC1 is due to the decrease
of the protein level, we performed a series of experiments
where an increasing amount of DNA encoding these pro-
teins was transfected and luciferase measurement was per-
Figure 2. SC1 is a repressor that requires its 
zinc finger domains and the PR/SET domain for 
repression. (A) Histogram of representative relative 
luciferase units after a cotransfection of Gal4 or 
Gal4SC1 with the Gal4-luc reporter (lanes 1 and 2, 
respectively) or TATA-luc reporter (lanes 3 and 4, 
respectively) in HEK293 cells. Whole-cell extracts 
were used in the luciferase assays and -galactosi-
dase measurements. The basal promoter activity 
was measured in the presence of Gal4 alone 
(black bar), and SC1’s regulation of the basal 
promoter was compared with it (open bar). A schematic map of the reporter construct is represented on the top. The graph shows the result of 
one experiment performed in triplicate that was reproduced in several independent experiments. (B) Left: histogram of relative luciferase units 
measured after cotransfection of various truncated mutants of SC1 fused to the Gal4-DBD represented schematically on the right. The numbers 
on the schematic drawings specify the amino acids of SC1. PR, PR/SET domain; ZF, zinc finger domain; Ac, an acidic COOH-terminal portion 
of SC1 protein. Black bar represents relative luciferase units in a control cotransfection experiment using Gal4 alone as an effector; white bars 
represent the results of cotransfection with various Gal4SC1 mutants. (C) Western blot showing the expression of Gal4-SC1 fusion proteins in 
HEK293 cells, as detected by anti-Flag antibody. Fusion proteins were immunoprecipitated from whole-cell lysates with anti-Flag antibody 
and separated on a 7.5% SDS-PAGE before blotting and detection with anti-Flag antibodies. The graph below demonstrates the results of the 
control transfections where increased amount of cDNA coding for the deleted SC1 proteins with lower expression levels were tested for their 
ability to influence luciferase measurements. The amounts of DNA used are shown below the appropriate construct (compared with the 0.3 g 
normally used in these experiments).
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formed. We obtained similar results in these experiments
(Fig. 2 C, bottom graph).
As many transcriptional repressors recruit HDACs
and need this activity to exert their repression (Grunstein,
1997; Pazin and Kadonaga, 1997; Wolffe, 1997), we tested
whether TSA, a potent inhibitor of HDACs, influences the
repressive activity of SC1 in the transcriptional reporter as-
says. Fig. 3 A shows that the repressive activity of SC1 was
completely abolished by the addition of 50 ng/ml TSA, in-
dicating that SC1’s repression relies on the activity of TSA-
sensitive HDACs. To directly test the interaction between
SC1 and HDACs, we cotransfected Flag-tagged SC1 with
HA-tagged HDAC 1, 2, or 3 into HEK293 cells and per-
formed a coimmunoprecipitation assay. Anti-Flag Sepharose
was used to bring down the Flag-tagged SC1. Expression of
the fusion proteins was monitored by Western blot analysis.
Cotransfection of Flag-vector with HDACs was used as a
negative control. The results of these experiments are pre-
sented in Fig. 3 B, which demonstrated that SC1 can be
found in a complex containing all the tested HDACs. Thus,
SC1 associates with the class I HDACs and is likely to exert
its repression by the recruitment of these proteins to the ap-
propriate promoter sites.
 
The zinc finger domains and the PR/SET domain of SC1 
are necessary to block BrdU incorporation
 
The zinc finger domains of SC1 are required for both nu-
clear localization and transcriptional repression, whereas the
PR/SET domain is involved in the modulation of the repres-
sive activity by SC1. In this work, we investigated whether
the deletion of zinc finger domains or the PR/SET domain
would influence BrdU incorporation. Full-length and trun-
cated forms of SC1 fused to either GFP or Gal4-DBD were
used for this investigation. Fig. 4 summarizes the results
from transfections of COS1 cells and Schwann cells with the
GFP-SC1 fusion proteins. The data were normalized with
respect to the BrdU incorporation of cells expressing GFP
alone (Fig. 4, A and B). The quantification of nuclei that
have incorporated BrdU upon transfection with the various
SC1 truncated proteins revealed that the deletion of zinc fin-
ger or the PR/SET domains resulted in an inability to block
BrdU incorporation. Fig. 4 A contains the results for 
 

 
PR
and 
 

 
ZF in COS1 cells. Fig. 4 B contains the results for
 

 
PR and 
 

 
ZF in Schwann cells and the respective quantifi-
cations. Overexpression of both the full-length and COOH-
terminally truncated SC1 protein led to a block of DNA
synthesis to the same extent (Fig. 4, A and B). These experi-
ments verified that the zinc fingers are necessary for nuclear
entry of SC1. On the other hand, deletion of the PR/SET
domain led to a loss of BrdU incorporation, even though the
SC1
 

 
PR protein remained in the nucleus. Hence, the PR/
SET domain is involved in the regulation of BrdU incorpo-
ration by SC1.
To characterize the transcriptional activity of SC1 further,
we used the Gal4-SC1 constructs used previously for the re-
porter gene assays. In contrast to the GFP fusion proteins
used for experiments with COS1 and Schwann cells, SC1
deletion proteins were tethered to the Gal4-DBD with an
endogenous NLS (see Fig. 5, A and C, for immunocy-
tochemical detection of overexpressed proteins). This al-
lowed us to establish a correlation between SC1’s repressive
activity and its ability to influence BrdU incorporation. As
described in the previous paragraph, we normalized the
BrdU incorporation data with respect to Gal4-DBD–trans-
fected cells. Again, we observed a loss of SC1’s capacity to
block BrdU incorporation in the absence of its zinc finger
domains (Fig. 5, B and D, lane SC1
 

 
583–798 for the re-
spective quantification of BrdU incorporation in NIH3T3
and HEK293 cells, respectively). Overexpression of both
full-length SC1 (Fig. 5, B and D, lane SC1FL for NIH3T3
and HEK293 cells, respectively) and a COOH-terminally
truncated SC1 (Fig. 5, B and D, lane SC1
 

 
754–798 for
NIH3T3 and HEK293 cells, respectively) resulted in much
Figure 3. SC1 forms a complex with HDACs 1, 2, and 3, and its 
repression is TSA sensitive. (A) Repression of the Gal4-luc promoter 
is abolished by the addition of 50 ng/ml TSA to the transfected HEK293 
cells. Relative luciferase activity was measured as described in 
Fig. 2 A. Black bars represent the control measurement with Gal4 
only as an effector; open bars represent the measurement with 
Gal4SC1 as an effector. (B) SC1 coprecipitates with HDACs 1, 2, 
and 3 when cotransfected in HEK293 cells. Proteins from transfected 
cell lysates were immunoprecipitated using anti-Flag M2 Sepharose, 
separated by SDS-PAGE, and immunoblotted with either anti-Flag 
M2 antibody for SC1 or anti-HA antibody for HDACs. The bottom 
panel shows input of HDACs.
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lower BrdU incorporation in both cell lines. Thus, SC1’s re-
pressive transcriptional activity could be involved in the im-
plementation of the growth arrest in these cells.
 
The influence of NGF on the transcriptional 
activity of SC1
 
SC1 was originally isolated as a protein that interacts with
the cytoplasmic domain of p75NTR, and its subcellular dis-
tribution was shown to be regulated by NGF. Therefore, we
sought to investigate whether its transcriptional activity is
regulated by the addition of NGF. To investigate this, we
transfected HEK293 cells with Gal4-SC1 fusion protein as
well as either TrkA or p75NTR and luciferase cDNAs under
the control of Gal4 promoter as a reporter. Expression of
p75NTR or TrkA was monitored by Western blotting after
transfection (unpublished data). NGF was applied for either
1 or 5 h, and the luciferase activity was measured afterwards.
We observed that coexpression of TrkA with SC1 led to a
potentiation of the repressive activity of SC1 (see Fig. 6 A
for the graphic representation of the relative luciferase units
measured in these experiments). To verify the specificity of
TrkA’s influence on the repressive activity of SC1, we used
K252a, a potent inhibitor of Trk signaling, and SC1’s tran-
scriptional output was then evaluated. Addition of K252a
led to a loss of the potentiation of SC1’s repressive activity as
measured by the reporter assay (refer to Fig. 6 A for the
graphic representation of these results). This observation im-
plicates TrkA in the regulation of SC1’s transcriptional ac-
tivity. In the cotransfection experiments with p75NTR,
SC1’s repressive activity also correlated with the addition of
NGF to the transfected cells. Thus, the addition of NGF for
1 h activated the repressive activity of SC1, and this activity
increased over time as can be seen from the 5-h measure-
ment (see Fig. 6 B for the graphic representation of SC1’s
transcriptional activity in the presence of p75NTR and
NGF). Hence, SC1 is a transducer of both TrkA and
Figure 4. Zinc finger and the PR/SET domains of SC1 are required for its ability to block BrdU incorporation. COS1 (A) and Schwann (B) 
cells transiently transfected with GFP and GFP-SC1 fusion protein constructs. (a) GFP transfected cells, (b) GFP-SC1 transfected cells, (c) GFP-
SC1PR transfected cells, (d) GFP-SC1ZF transfected cells, (e) GFPC transfected cells. Cells were stained with antibodies against GFP and 
BrdU. GFP is labeled with FITC-coupled secondary antibodies (green), and BrdU with rhodamine-coupled secondary antibodies (red). Arrowheads 
indicate cells positive for BrdU incorporation after expression of SC1. Histograms represent the percentage of cells that express GFP or GFP-SC1 
and incorporate BrdU. Data were normalized with respect to the BrdU incorporation of cells expressing GFP (mean and SD of at least three 
different experiments are shown). Bars, 20 m.
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p75NTR receptor signaling, and its activity is regulated by
these two receptors.
 
SC1 represses transcription of genes that drive 
cell cycle progression
 
The fact that SC1’s transcriptional activity influenced BrdU
incorporation led us to test the possibility that SC1 may re-
press the expression of promitotic genes. To this end, we
used a reporter gene system where the expression of cell cy-
cle–related genes was assayed using a luciferase reporter as-
say. We used 
 
cyclin E
 
, 
 
cyclin A
 
, and 
 
cyclin B
 
 promoters for
this analysis. The 
 
cyclin E
 
 promoter contained 1.4 kb of the
sequence upstream of the transcription start site, which has
been shown to regulate its transcription during G1 phase
(Geng et al., 1996); the 
 
cyclin A
 
 promoter contained 3.2 kb
of the sequence upstream of the transcription start site
known to regulate its transcription during S phase (Yoshi-
zumi et al., 1995); and the 
 
cyclin B1
 
 promoter contained 3.8
bp upstream of the transcription start site. This sequence has
been shown to enhance its transcription during G2 phase
(Cogswell et al., 1995). Flag-tagged full-length SC1 was
used as an effector, and the cyclin promoter-specific driven
luciferase constructs were used as reporters. NIH3T3 cells
were synchronized by serum withdrawal (see the Materials
and methods section) for 48 h and released from growth ar-
rest by the addition of serum-containing medium.
First, we determined the time course of expression of 
 
cy-
clins E
 
,
 
 A
 
,
 
 and B
 
 in these cultures by performing Northern
blots at 0, 4, 8, 12, 16, 20, and 24 h after serum addition.
 
Cyclin E
 
 could be detected at 12 h first and persisted until
24 h, 
 
cyclin A
 
 could first be detected at 20 h, and 
 
cyclin B
 
was first detected at 24 h after serum addition of the
growth-arrested cells (unpublished data). The cells were
transfected with either SC1-bearing plasmid or a control
plasmid, and lysates were collected at the following time
points after serum addition: at 12 h for 
 
cyclin E
 
 measure-
ment; at 20 h for 
 
cyclin A
 
 measurement; and at 24 h for 
 
cy-
clin B
 
 measurement. Subsequently, luciferase activity was
measured in these lysates. We observed that 
 
cyclin E
 
 was
down-regulated as measured by the luciferase activity, and
the repression of the 
 
cyclin E
 
 promoter was comparable in
magnitude to the repression exerted by SC1 when it is teth-
ered to the Gal4 moiety (compare Fig. 7 A with Fig. 2 A).
There was also a slight reduction of 
 
cyclin B
 
 expression as
measured by the luciferase activity (Fig. 7 C). Expression of
 
cyclin A
 
, the major cyclin acting during S phase of the cell
cycle, was not down-regulated by SC1 in these experiments
(Fig. 7 B). To verify that the cyclin genes are expressed in
these cells, we performed RT-PCR to monitor the endoge-
nous expression of the cyclins (Fig. 7). Then, we investi-
gated whether the levels of endogenous cyclin E protein
were affected by the overexpression of SC1. To this end, we
analyzed the protein lysates from NIH3T3 cells that had
been transfected with either SC1 or a control Flag-bearing
plasmid and treated as described above. Equal amounts of
 
Figure 5.
 
Correlation of transcriptional activity with SC1’s ability to 
block BrdU incorporation.
 
 NIH3T3 (A and B) and HEK293 (C and D) 
cells transiently transfected with Gal4SC1 fusion protein constructs. 
(A) SC1-expressing cells (green) are visualized by FITC-coupled 
anti-Flag antibodies. Bottom: the same field showing BrdU-labeled 
cells. (B) Histogram represents the percentage of cells transfected with 
Gal4, Gal4SC1FL, Gal4SC1
 

 
754–798, and Gal4SC1
 

 
583–798, 
which incorporated BrdU (mean and SD of at least three different 
experiments are shown). C and D are the same as A and B for HEK293 
cells. Arrows indicate the cells transfected with SC1 constructs and 
the corresponding BrdU incorporation into their nuclei. Bars, 20 
 

 
m.
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total protein were loaded on the gels, which were then
transferred for Western blot analysis. We used an anti-
cyclin E antibody to detect the levels of total cyclin E pro-
tein in these lysates, and normalized these by probing the blots
with an anti-actin antibody (Fig. 7 D). The images were an-
alyzed using a densitometer to determine the relative levels
of cyclin E and actin present in transfected and mock-trans-
fected cells, and were corrected for the transfection effi-
ciency of these cells (which was routinely between 30 and
40%). We calculated a reduction of the total cyclin E pro-
tein level by a factor of 2.5 in cells overexpressing SC1, sup-
porting our previous observations on the repression of the
 
cyclin E
 
 promoter in the reporter assays (see Fig. 7 A).
Our observations that SC1 represses the expression of 
 
cy-
clin E
 
 and that its activity is regulated by both TrkA and
p75NTR led us to test the validity of these observations in a
well-characterized cell line used in studying neurotrophin
signaling, namely PC12 cells. Thus, the cells were synchro-
nized using the method of Rudkin et al. (1989) by serum
withdrawal, released from the cell cycle block by the addi-
tion of different factors, and samples to be analyzed were
taken at 
 

 
50 h after transfection for luciferase measurement
(expression of the endogenous 
 
cyclin E
 
 at this time was veri-
fied by performing RT-PCR; unpublished data). We tested
the effects of NGF on the repression of the 
 
cyclin E
 
 pro-
moter by SC1. The results of these experiments are summa-
rized in Fig. 8. Application of NGF to these cells enhanced
the repression of 
 
cyclin E
 
 promoter by SC1. These observa-
tions implicate SC1 in the control of cell cycle progression
and make it an important component of NGF signaling.
Next, we investigated the role of the endogenous SC1 in
regulating 
 
cyclin E
 
 expression in PC12 cells. To this end, we
used the small interfering RNA (siRNA) method to block
the expression of endogenous SC1 in PC12 cells, and mea-
sured the levels of cyclin E proteins in the lysates of trans-
fected or mock-transfected cells. In parallel experiments with
GFP expression plasmids, transfection rates in PC 12 cells
were in the range of 30–50%, and thus resembled those in a
recent paper (Rossoll et al., 2003). This corresponded to a
reduction of SC1 by 40–60% in our experiments (Fig. 9).
Down-regulation of SC1 leads to a significant increase in cy-
clin E expression, whereas the levels of cyclin A are not mod-
ified (Fig. 9), consistent with our observations in NIH3T3
cells as measured by luciferase reporter gene assays (Fig. 7, A
and B). The quantification of the expression levels of SC1,
cyclin E, and cyclin A proteins in PC12 cell lysates trans-
fected with either SC1 siRNA or a scrambled siRNA con-
struct is presented in Fig. 9 B. These experiments clearly
show the involvement of endogenous SC1 in the regulation
of transcription of 
 
cyclin E
 
, but not 
 
cyclin A
 
 in PC12 cells.
 
Discussion
 
Transcriptional regulation through chromatin modification
is emerging as one of the crucial ways to control differentia-
tion during development. In this paper, we describe a func-
tion of SC1, a novel p75NTR-interacting zinc finger protein
with a PR/SET domain. We present evidence that SC1 can
act as a transcriptional repressor, it is found in a complex
with HDACs 1, 2, and 3, and its activity is sensitive to TSA.
Additionally, we demonstrate here that zinc finger domains
are required for multiple functions of SC1 (i.e., nuclear lo-
calization, transcriptional repression, and SC1’s ability to
negatively influence DNA replication). The PR/SET do-
main is involved in transcriptional repression and decreases
BrdU incorporation. Further, we present evidence that SC1
Figure 6. Regulation of SC1’s repressive activity by TrkA, p75NTR, and NGF. (A) HEK293 cells were transiently transfected with TrkA and 
Gal4DBD-SC1, and Gal4-luc was used as a reporter. Cultures were either left in low serum-containing medium (1% FCS) or treated with NGF 
for the indicated amount of time. Relative luciferase activity (RLU) was measured in these lysates and normalized for transfection efficiency by 
cotransfection with -galactosidase and by measuring the latter’s activity. (B) Same as in A, except that p75NTR was used in these cotransfection 
experiments instead of TrkA. The results represent a mean of an experiment performed in triplicate and its SD; these were reproduced in 
several independent experiments.
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can down-regulate the expression of 
 
cyclin E
 
, which is instru-
mental for the S-phase entry during cell cycle (Ewen, 2000).
This down-regulation is observed in both NIH3T3 cells and
in PC12 cells where the effect is enhanced by NGF.
Analysis of the transcriptional activity by SC1 revealed that
it acts as a transcriptional repressor both in the context of be-
ing tethered to a DBD of another protein, Gal4, and by itself
in transfection experiments. Our data indicate that the six
zinc finger domains and the PR/SET domain are required for
transcriptional repression by SC1. This implicates the zinc
finger’s and PR/SET domain’s direct involvement in tran-
scriptional activity either by allowing DNA binding of SC1
or by recruitment of other proteins that may modulate tran-
scriptional repression. Consistent with the latter hypothesis,
we observed that SC1 exerts its repressive activity by recruit-
ing TSA-sensitive HDACs. Complexes involving HDACs
have been implicated in silencing neuronal-specific genes
(Naruse et al., 1999; Ballas et al., 2001). SC1 is an HDAC-
dependent repressor, which may be involved in actively pre-
disposing cells for differentiation by blocking their prolifera-
tive potential through down-regulation of promitotic genes.
Interestingly, truncation of the region of SC1 that con-
tains the PR/SET domain transforms SC1 into a transcrip-
tional activator, thus pointing to an involvement of this do-
main in repressive activity of SC1. Similar observations were
made when Blimp-1’s PR domain was removed (Yu et al.,
Figure 7. SC1 represses transcription of cyclin E in NIH3T3 cells. 
Flag-SC1FL constructs were used as effectors in this work, and were 
cotransfected with the indicated cyclin-specific driven luciferase 
gene. The two right bars on the graphs are shown to indicate that 
pGL reporter (luciferase under the basic promoter) is not influenced 
by the expression of SC1 as compared with control Flag plasmid. (A) 
Histogram of representative relative luciferase units measured after 
a cotransfection of SC1 with cyclin E-luc reporter. Luciferase activity 
was measured upon cotransfection with Flag-only vector as a control 
(black bars) and with Flag-SC1 fusion protein (white bars). The 
schematics of reporter promoters are shown below the histograms 
for each pair of effectors. An inset shows the results of a cyclin
E–specific RT-PCR; , reactions where RT was performed; , the 
reaction where no RT was performed before PCR. (B) Same as in A, 
but with the cyclin A-luc reporter. (C) Same as in A, but with the 
cyclin B-luc reporter. (D) A Western blot showing the levels of 
endogenous cyclin E upon transfection with either SC1 or a control 
vector (top). Lane 1 shows the cyclin E levels before release from cell cycle arrest, lane 2 shows cyclin E in mock-transfected cells, and lane 3 
shows cyclin E levels in SC1-transfected cells 12 h after release from the cell cycle block. Bottom: levels of actin in the same lysates; the 
numbering of lanes is the same as for the top panels.
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2000). In this respect, it is noteworthy that two related pro-
teins (RIZ and MDS1-EVI1) encode two different tran-
scripts, which differ only in the presence of the PR/SET do-
main in the respective proteins (Bartholomew and Ihle,
1991; Liu et al., 1997). The absence of the PR/SET domain
correlates with a weaker repressive activity in RIZ protein
(Xie et al., 1997), suggesting a modulatory role of PR/SET
domains during repression. Additionally, Blimp-1/PRDF-
BF1 can exert repression through its PR/SET domain (Ghosh
et al., 2001).
SET domains are found in chromosomal proteins that
modulate gene expression and chromatin structure (for
review see Jenuwein, 2001). Several proteins containing SET
domains possess lysine histone methyltransferase activity
(O’Carroll et al., 2000; Rea et al., 2000; Strahl et al., 2002).
These histone modifications can lead to transcriptional re-
pression (Firestein et al., 2000), but other enzymes are likely
to be required, e.g., HDACs, to act together with methyl-
transferases. We do not know whether the PR/SET do-
main of SC1 possesses a protein methyltransferase activity.
However, given SC1’s ability to repress transcription in an
HDAC-dependent manner, it would make SC1 a prime can-
didate for developmental regulation and subsequent mainte-
nance of differentiation. Such a role is further substantiated
by the observation that SC1’s action is correlated with a block
of BrdU incorporation, suggesting a role in cell differentiation
and possible maintenance of the differentiated state.
One of the genes whose transcription is negatively regu-
lated by SC1 is 
 
cyclin E,
 
 the major cyclin at G1–S phase
transition. The down-regulation of 
 
cyclin E is consistent
with the hypothesis that SC1 may play a major role at the
G1–S decision making stage, and possibly during terminal
mitosis as the cells prepare to enter a differentiative program.
A down-regulation of cyclin E mRNA was observed by
Tramtrack protein during glial development in Drosophila
melanogaster, blocking entry into S phase and thus regulat-
ing glial cell proliferation (Badenhorst, 2001). Additionally,
the activity of cyclin E together with CDK2, its binding
partner, is instrumental for the regulation of cell cycle pro-
gression in neural and glial progenitor cells, and its block
leads to an efficient cell cycle arrest (Casaccia-Bonnefil et al.,
1999; Ferguson et al., 2000). Thus, SC1 may be one of the
key regulators determining the decision of proliferating cells
to exit cell cycle in the nervous system.
Several interesting points arise concerning the possible
role of SC1 in neurotrophin signaling. It has been shown
that in PC12 cells, the responsiveness to NGF is cell cycle
stage-dependent (Rudkin et al., 1989), i.e., they will re-
spond by differentiating when in G1 phase, but progress
through the cell cycle when exposed to NGF during the
other cell cycle phases (van Grunsven et al., 1996a,b). This
responsive difference to NGF can be partially explained by
the different temporal cell surface expression of TrkA and
p75NTR (Urdiales et al., 1998). Thus, TrkA is observed on
the cell surface during late M/early G1 phase, whereas
p75NTR is highly expressed at the surface during the re-
maining time of cell cycle. Consistent with this temporal
expression of the two NGF receptors, SC1 may act as a
transducer of anti-proliferative signaling by NGF at an ap-
propriate cell cycle stage, i.e., at G1–S transition as a
blocker of further S phase entry. We observed that both
TrkA and p75NTR enhanced the repressive activity of SC1
in our cotransfection experiments, implying the role of SC1
Figure 8. SC1 represses transcription of cyclin E in PC12 cells. 
Flag-SC1FL or Flag-only expression plasmids were used in these 
experiments. Cells were treated as indicated, and the luciferase 
activity was measured 50 h after transfection and release from the 
cell cycle block. The results represent the mean of an experiment 
performed in triplicate and its SD; these were reproduced in several 
independent experiments.
Figure 9. Endogenous SC1 down-regulation by siRNA in PC12 cells 
increases the expression of cyclin E, but not cyclin A. (A) PC12 
cells were transfected with scrambled (mock) or SC1 siRNA (SC1), 
serum starved for 24 h, and collected 24–48 h after serum addition. 
Western blotting was performed to detect SC1, cyclin E, cyclin A, 
and actin. Representative blots are shown. (B) Quantification of SC1, 
cyclin E, and cyclin A expression in SC1 siRNA-transfected cells. 
Relative amounts were normalized with respect to the amounts of 
the corresponding cyclin or SC1 in mock siRNA-transfected cells 
(100%). The results are the mean  SD of three independent exper-
iments. Note the reduction in the amount of SC1, which corresponds 
to the increase in the amount of cyclin E in extracts from SC1 siRNA-
treated PC12 cells. Significance of these results was tested using a 
t test with P  0.05 for cyclin E and SC1. n.s., not significant.
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as the transducer of NGF signaling by these two receptors.
This observation is particularly interesting in view of our
data, showing that NGF enhances the repressive activity of
SC1 at the cyclin E promoter in PC12 cells. As such, SC1
could play a decisive role during the differentiation of PC12
cells upon NGF addition. Specifically, as the decision to
exit the cell cycle is made during G1 phase in these cells and
both TrkA and p75NTR are expressed at this stage, they
would be involved in mediating the anti-mitogenic re-
sponse through SC1 as one of the key players in this pro-
cess. The observations presented here offer novel venues for
probing the molecular mechanism of NGF action as it is
transduced by both TrkA and p75NTR through the activa-
tion of SC1.
Materials and methods
Cells lines, transfections, and reporter gene assays
HEK293 cells and NIH3T3 cells were kept in DME supplemented with
10% FCS unless otherwise indicated. We used a subline of PC12 cells,
PC6-3 (a gift of Jonathan Ham, Institute of Child Health, London, UK; Pitt-
man et al., 1993). These were grown in DME with 10% horse serum and
5% FCS, except for the synchronization experiments and treatment with
growth factors where low serum was used (1% horse serum and 0.5%
FCS). Synchronization was done according to a published protocol (Rud-
kin et al., 1989) where cells were kept without serum for 3 d and then re-
leased from the cell cycle block by the addition of either 100 ng/ml NGF
or serum. For synchronization of NIH3T3, we used a previously published
method (Kerkhoff and Rapp, 1997). In brief, the cells were arrested by
keeping them in low serum (0.5% FCS) for 48 h, and were released from
growth arrest by the addition of full serum-containing medium. In the ex-
periments with K252a, the latter was added to the cells at a final concen-
tration of 0.2 M for 30 min before NGF addition. Transfections were
performed using the LipofectAMINE™ 2000 kit according to the manu-
facturer’s instructions (Invitrogen). 24-well plates were used for all the
experiments, and the amount of DNA was kept constant, as suggested
by the manufacturer. For TSA (Upstate Biotechnology) treatment of trans-
fected cells, TSA was dissolved in DMSO and added directly to the trans-
fected cells at a final concentration of 50 ng/ml for 16 h. DMSO was
added to mock-treated cells in control reactions. Cells were lysed in the lu-
ciferase assay buffer as suggested by the manufacturer (Promega), and lu-
ciferase activity was measured using a luminometer (Berthold). As an inter-
nal control for transfection efficiency, -galactosidase–expressing plasmid
(pCMV-gal) was cotransfected with the reporter and effector plasmids.
The data were normalized to the -galactosidase activity. Luciferase activ-
ity measurement was corrected for the transfection efficiency by calculat-
ing the ratio of luciferase units to -galactosidase units, represented as the
relative luciferase units. Transfections of COS1 and primary Schwann cells
were performed using the Effectene Kit (QIAGEN) following the instruc-
tions of the vendor. Primary Schwann cells were isolated from P1 sciatic
nerve according to a previously published protocol (Tikoo et al., 2000).
Plasmids
We used 0.75 g 5xGal4 UAS-luciferase DNA (a gift of Al Fisher, Cornell
University Medical College, New York, NY; Catron et al., 1995); 0.25 g
Gal4SC1 or other deletion mutants of SC1, and 0.05 g pCMV-gal DNA
for transfections of HEK293 cells. The same relative ratios and amounts of
plasmid DNA were used for transfections with cyclin-specific luciferase
constructs. Reporters were used as follows: pGL2-cyclin E-luc containing
1.4 kb of cyclin E promoter; pGL2-cyclin B-luc containing 3.8 kb of the cy-
clin B promoter; and pGL2-cyclin A-luc containing 3.5 kb of cyclin A
promoter (all these were gifts of E. Kerkhoff, University of Würzburg). As
an effector, pSC1 construct was used, which is an NH2-terminal fusion of
full-length SC1 with a Flag tag (Chittka and Chao, 1999). GFP fusion pro-
teins were generated as follows: full-length SC1, SC1ZF (deletion from
H608 to H744) and SCC (deletion from K749 to the end of the protein)
were subcloned into pEGFP-C3 (CLONTECH Laboratories, Inc.) using
HindIII and BamHI restriction sites. SC1ZF was created by generating an
NdeI site in the full-length cDNA. Subsequent digestion with NdeI resulted
in a construct without the zinc fingers. SC-1PR was created by generating
a PstI restriction site in the full-length cDNA. Digestion with PstI resulted
in a construct without the PR domain. HA-tagged HDAC 1-, 2-, and
3-bearing plasmids were gifts of R. Evans (The Salk Institute for Biological
Studies, La Jolla, CA). The TATA-luc plasmid was a gift of Heike Boemmel
(University of Würzburg).
Immunocytochemistry
For the experiments using NIH3T3 and HEK293 cells, BrdU was purchased
from Sigma-Aldrich and used according to a previously published protocol
(Krek and DeCaprio, 1995). Cells were plated on sterile glass coverslips
coated with poly-ornithine and were pulsed for 2–3 h with 10 M BrdU be-
fore fixation with cold 50:50 methanol/acetone for 2–3 min. Immunostain-
ing was performed as suggested by the manufacturer of the anti-BrdU anti-
body kit (Zymogen). Immunostaining of labeled cells with a monoclonal
anti-FLAG FITC-conjugated antibody (Upstate Biotechnology) to visualize
SC1-expressing cells was performed according to the manufacturer’s in-
structions. Coverslips were embedded in Mowiol after washing. COS1 and
Schwann cells were plated as above, except that poly-D-lysine was used for
coating the coverslips. They were pulsed for 24 h with 10 M BrdU before
processing for immunocytochemistry. The cells were fixed in 4% PFA in
PBS. Primary anti-BrdU antibody from DakoCytomation was used, with
subsequent visualization by application of anti–mouse rhodamine-conju-
gated secondary antibody from Jackson ImmunoResearch Laboratories.
Scans of stained cells were made using a confocal microscope (model TCS;
Leica) for NIH3T3, COS1, and Schwann cells with identical settings for pin-
hole and voltage for any panel of analysis, and a fluorescent microscope
(model IX70; Olympus) was used for HEK293 cells.
RT-PCR for cyclin-specific mRNA
RNA was extracted from the cells using TRIzol® (Invitrogen), according to
the manufacturer’s instructions. RT-PCR was performed using the Super-
Script™ II kit (Invitrogen). Primers were used as follows: cyclin E, forward:
5-GTGAAAAGCGAGGATAGCAG-3, reverse: 5-TGTTGTGATGCCATG-
TAACG-3; cyclin B, forward: 5-GGCACTGTTAAAGCCCTACC-3, re-
verse: 5-GTTCTGCATGAACCATC-3; and cyclin A, forward: 5-AAGGAC-
CTTCCTATAAAC-3, reverse: 5-TTCTCCCACCTCAACCAG-3. Cycling
was performed as follows: for cyclin E and cyclin B: 5 min at 94	C for 1 cy-
cle; 30 s at 94	C, 30 s at 53	C, 30 s at 72	C for 30 cycles; 10 min at 72	C for
1 cycle. For cyclin A, the annealing was performed at 50	C.
Co-immunoprecipitation experiments and Western blotting
Co-immunoprecipitations of Flag-SC1 and HDACs were performed as fol-
lows: HEK293 cells were transfected with either Flag-SC1 or Flag alone
and HDAC 1, 2, or 3, and were harvested 48 h after transfection. Cells
were lysed using RIPA buffer on ice and centrifuged to get rid of cell de-
bris. Lysates were then precleared using protein A/G beads (Amersham
Biosciences) and Flag-tagged proteins were precipitated using anti-Flag
M2 Sepharose (Sigma-Aldrich). The beads were then washed with RIPA
buffer 4–5 times and the immune complexes were separated by SDS-
PAGE. Half of the reaction was run out on a 10% gel, blotted and probed
for HDACs using anti-HA antibody (Santa Cruz Biotechnology, Inc.); an-
other half was separated on a 7.5% gel, blotted and probed with anti-Flag
M2 antibody (Sigma-Aldrich) to detect SC1. For Western blotting with
anti-cyclin E antibody, we used a polyclonal antibody (Santa Cruz Bio-
technology, Inc.); the anti-actin mouse monoclonal antibody was from
DakoCytomation.
siRNA experiments
SC1 siRNA was obtained using the Silencer™ siRNA Cocktail Kit (RNase
III; Ambion). As a template for the in vitro transcription, a fragment of 1.2
kb corresponding to nucleotides 1–1200 of the rat SC1 sequence was sub-
cloned in pcDNA3 in both orientations. PC12 cells were transfected with
SC1 siRNA or scrambled siRNA (0.5 g/well) using LipofectAMINE™
2000. 24 h later, cells were serum starved for 24 h. Serum-containing me-
dium was added, and 24–48 h later, cells were collected directly in pro-
tein loading buffer and boiled for 5 min. Western blotting was performed
to determine levels of SC1, cyclin E, cyclin A, and actin.
SC1 antibodies
Antibodies against SC1 were obtained from rabbits injected with the pep-
tide GSMTTEGCRMSSAVYSADESLSAHKC coupled to KLH. Antibodies
were purified using an affinity column with the peptide coupled to CNBr
Sepharose (Roche). Antibodies were used at 2 g/ml for Western blotting.
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